Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(626/week)
Manufacturing
(450/week)
Energy
(343/week)
Technology
(477/week)
Other Manufacturing
(372/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Testosterone undecanoate
May 15, 2020
Lipocine Announces Presentations on TLANDO(TM) at AUA Virtual Experience 2020
May 13, 2020
Treatment Potential of LPCN 1144 Demonstrated in a Pre-Clinical NASH and Hepatic Fibrosis Model
May 05, 2020
FDA Clears LPCN 1148 IND Application for Phase 2 Cirrhosis Trial
Apr 17, 2020
U.S. FDA Denies Clarus's Oral Testosterone Ester Citizen Petition
Feb 11, 2020
Lipocine Streamlines Its Infringement Lawsuit Against Clarus Therapeutics
Nov 11, 2019
Lipocine Receives Complete Response Letter for TLANDO(TM) from U.S. FDA
Oct 10, 2019
Lipocine to Present at the H.C. Wainwright 3rd Annual NASH Investor Conference
Oct 01, 2019
Lipocine To Present LPCN 1144 Poster Of Distinction At The Liver Meeting® 2019
Sep 30, 2019
First Biopsy Confirmed Nash Patient Dosed In Lipocine LiFT Study Of LPCN 1144
Sep 23, 2019
Lipocine Announces Presentations at the 20th Annual Fall Meeting of the Sexual Medicine Society of North America
Sep 17, 2019
Lipocine to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Aug 27, 2019
Lipocine Announces Trial Date in Lipocine's Infringement Lawsuit Against Clarus Therapeutics and Will Seek a Permanent Injunction
Jul 23, 2019
Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Population
Jun 27, 2019
Hypogonadism Market Spotlight 2019 - Clinical Trial Activity is Dominated by Completed Trials, and AbbVie Leads with 8 Completed Trials
Mar 14, 2019
Lipocine Announces Presentation Highlighting Therapeutic Potential of LPCN 1144 in NAFLD and NASH Selected for ENDO 2019
Oct 11, 2018
Lipocine Announces LPCN 1144 Clinical Trial Results Selected for Late-Breaker Presentation at The Liver Meeting® 2018
Latest News
May 7, 2024
Hayward Cuts Ribbon on Hayward Hub DFW
May 7, 2024
Otter Tail Corporation Announces First Quarter Earnings and Increases 2024 Annual Earnings Guidance
May 7, 2024
Redwire Selected by Rocket Lab to Provide Antennas for the Space Development Agency’s Transport Layer Tranche...
May 7, 2024
Winners of the Milken-Motsepe Prize in Green Energy Announced During Opening Session of Milken Institute...
May 7, 2024
Black Stone Minerals, L.P. Reports First Quarter Results
May 7, 2024
Genesis Energy, L.P. Upsizes and Prices Public Offering of Senior Notes
May 7, 2024
AST SpaceMobile Welcomes Andrew Johnson as New Chief Legal Officer
May 7, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter Results and File Quarterly Report on Form 10-Q on...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events